Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?

Volume VIII No. 5 - April 9, 2001

Identifying Future Lab Winners From Losers

Commentary and Opinion by R. Lewis Dark / By

TODAY I WOULD LIKE TO DO SOME CRYSTAL BALL-GAZING as a way to make a point about strategic business planning for laboratories. As you will read here, our Editor-In-Chief has analyzed the year-end balance sheets of the two newest publicly-traded laboratory companies. The purpose of his intelligence briefing is to assess the balance sheet strengths …

Identifying Future Lab Winners From Losers Read More »

To access this post, you must purchase The Dark Report.

THE DARK REPORT Honors Lab “Movers & Shakers”

Laboratory Management / By

CEO SUMMARY: It’s time again to recognize and honor the lab industry’s strong leaders in innovative management. These laboratory executives are implementing business strategies designed to position their lab organizations to serve the changing needs of the healthcare system. Their vision and willingness to “stay the course” are traits they hold in common. IT’S BEEN …

THE DARK REPORT Honors Lab “Movers & Shakers” Read More »

To access this post, you must purchase The Dark Report.

New Cytology Technology Entering Study Phase

Laboratory Equipment / By

CEO SUMMARY: There’s a new contestant in the ongoing battle to win the Pap smear technology wars. Ampersand Medical Corporation, by signing a strategic alliance with AmeriPath, Inc., has signaled that it’s ready to bring its technology to market. AmeriPath will play a major role in expediting clinical studies and both companies hope to formally …

New Cytology Technology Entering Study Phase Read More »

To access this post, you must purchase The Dark Report.

Tissue Banking May Be Source Of New Pathology Revenues

Pathology Trends / By

CEO SUMMARY: Evidence is accumulating that tissue banking may be where the “rubber meets the road;” where pharma money funds technology enhancements that directly benefit the profession of pathology. Without question, the need by pharma, biotech, and genomic companies to access, analyze and understand the tissue of targeted subpopulations is creating an opportunity for savvy …

Tissue Banking May Be Source Of New Pathology Revenues Read More »

To access this post, you must purchase The Dark Report.

Specialty Labs and Dynacare Have Balance Sheet Differences

Laboratory Management / By

SINCE LAST FALL’S SUCCESSFUL IPOs (initial public offering) raised $92 million for Specialty Laboratories, Inc. and $50 million for Dynacare, Inc., the financial fortunes of the two lab companies have begun moving in different directions. Lab administrators and pathologists can better understand the diverging business directions of Specialty Labs and Dynacare by studying each lab’s …

Specialty Labs and Dynacare Have Balance Sheet Differences Read More »

To access this post, you must purchase The Dark Report.

“April 9, 2001 Intelligence: Late Breaking Lab News”

Late Breaking Lab News / By

There’s another commercial laboratory working toward its ISO-9001 certification. CEO Roy Trucks of Doctors Laboratory, Inc. in Valdosta, Georgia reports that implementation of ISO-mandated procedures is going well. The goal is to pass the audit and receive the ISO-9001 certificate by October 2001. Trucks also indicates that the new management methods have already begun boosting …

“April 9, 2001 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

Facebook-f Twitter Linkedin-in

The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: info@darkreport.com

© 2024 The Dark Report. All rights reserved.

;